Nutex Health
NUTX----
Q2 FY2026 EarningsQ2 FY26 results beat consensus estimates significantly, driven by a one-time $52.3M non-cash accounting adjustment related to reduced arbitration fees. Net income was $65.8M vs. $35.9M expected, while diluted EPS of $9.38 far exceeded the $4.95 mean consensus. Revenue of $210.8M slightly missed the $215.0M estimate due to adjustments in variable consideration, despite a 9.6% increase in patient visits.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Nutex Health(NUTX) the Revenue is 210.75 M (-13.62%), Miss estimate;the EBIT is 121.72 M (+261.4%), Beat estimate;the EPS is 9.38 (+418%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.21B13.62%
0.22B11.87%
-0.00B1.75%
EBITExceed expectations
0.12B261.41%
0.07B114.46%
+0.05B146.95%
EPSExceed expectations
9.38417.97%
4.954267.93%
+4.4260150.04%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf